The effect of erythropoietin on cognition in affective disorders – Associations with baseline deficits and change in subjective cognitive complaints

European Neuropsychopharmacology

Volumn 26, Issue 8, 2016, Pages 1264-1273

  Ott, Caroline Vintergaard ^a   Vinberg, Maj ^a   Kessing, Lars V ^a   Miskowiak, Kamilla W ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Bipolar disorder; Cognitive impairments; Depressive disorder; Epoetin Alfa; Screening

Indexed keywords

PLACEBO; RECOMBINANT ERYTHROPOIETIN; NOOTROPIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY ANALYSIS; SELF REPORT; SOCIAL STATUS; WORK CAPACITY; AFFECT; COHORT ANALYSIS; DENMARK; DEPRESSION; DRUG EFFECTS; INTERNATIONAL CLASSIFICATION OF DISEASES; MIDDLE AGED; NERVOUS SYSTEM FUNCTION; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SOCIAL ADAPTATION;

ADULT; AFFECT; BIPOLAR DISORDER; COGNITION; COGNITION DISORDERS; COHORT STUDIES; DENMARK; DEPRESSIVE DISORDER; EPOETIN ALFA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MALE; MIDDLE AGED; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SELF REPORT; SOCIAL ADJUSTMENT;

EID: 84977553703     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2016.05.009     Document Type: Article

References (45)

1. Army Individual Test Battery, Manual of Directions and Scoring. 1944, War Department, Adjutant General׳s Office, Washington, DC.
2. Arts, B., Jabben, N., Krabbendam, L., van Os, J., Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol. Med. 38:6 (2008), 771–785, 10.1017/S0033291707001675.
3. Berk, M., Brnabic, A., Dodd, S., Kelin, K., Tohen, M., Malhi, G.S., McGorry, P.D., Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 13:1 (2011), 87–98, 10.1111/j.1399-5618.2011.00889.x.
4. Borkowski, J.G., Benton, A.L., Spreen, O., Word fluency and brain damage. Neuropsychologia 5 (1967), 135–140.
5. Bonnin, C.M., Reinares, M., Martínez-Arán, A., Balanzá-Martínez, V., Sole, B., Torrent, C., Tabarés-Seisdedos, R., García-Portilla, M.P., Ibáñez, A., Amann, B.L., Arango, C., Ayuso-Mateos, J.L., Crespo, J.M., González-Pinto, A., Colom, F., Vieta, E., Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory. Psychol. Med. 46:2 (2016), 291–301, 10.1017/S0033291715001713.
6. Bortolato, B., Miskowiak, K.W., Köhler, C.A., Maes, M., Fernandes, B.S., Berk, M., Carvalho, A.F., Cognitive remission: a novel objective for the treatment of major depression?. BMC Med., 14(1), 2016, 10.1186/s12916-016-0560-3.
7. Burdick, K.E., Endick, C.J., Goldberg, J.F., Assessing cognitive deficits in bipolar disorder: are self-reports valid?. Psychiatry Res. 136 (2005), 43–50.
8. Burdick, K.E., Braga, R.J., Nnadi, C.U., Shaya, Y., Stearns, W.H., Malhotra, A.K., Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction. J. Clin. Psychiatry 73:1 (2012), 103–112, 10.4088/JCP.11m07299.
9. Burdick, K.E., Ketter, T.A., Goldberg, J.F., Calabrese, J.R., Assessing cognitive function in bipolar disorder: challenges and recommendations for clinical trial design. J. Clin. Psychiatry 76:3 (2015), e342–e350, 10.4088/JCP.14cs09399.
10. Demant, K.M., Vinberg, M., Kessing, L.V., Miskowiak, K.W., Assessment of subjective and objective cognitive function in bipolar disorder: correlations, predictors and the relation to psychosocial function. Psychiatry Res. 229:1–2 (2015), 565–571, 10.1016/j.psychres.2015.05.022.
11. Demant, K.M., Vinberg, M., Kessing, L.V., Miskowiak, K.W., Effects of short-term cognitive remediation on cognitive dysfunction in partially or fully remitted individuals with bipolar disorder: results of a randomised controlled trial. PLoS ONE, 10(6), 2015, e0127955, 10.1371/journal.pone.0127955.
12. Ehrenreich, H., Fischer, B., Norra, C., Schellenberger, F., Stender, N., Stiefel, M., Sirén, A.L., Paulus, W., Nave, K.A., Gold, R., Bartels, C., Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain: J. of Neurol., 130, 2007, 2577–2588, 10.1093/brain/awm203.
13. Ehrenreich, H., Hinze-Selch, D., Stawicki, S., Aust, C., Knolle-Veentjer, S., Wilms, S., Heinz, G., Erdag, S., Jahn, H., Degner, D., Ritzen, M., Mohr, A., Wagner, M., Schneider, U., Bohn, M., Huber, M., Czernik, A., Pollmächer, T., Maier, W., Sirén, A.L., Klosterkötter, J., Falkai, P., Rüther, E., Aldenhoff, J.B., Krampe, H., Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol. Psychiatry 12:2 (2007), 206–220, 10.1038/sj.mp.4001907.
14. Fava, M., Iosifescu, D.V., Pedrelli, P., Baer, L., Reliability and validity of the massachusetts general hospital cognitive and physical functioning questionnaire. Psychother. Psychosom. 78:2 (2009), 91–97, 10.1159/000201934.
15. Fisher, M., Loewy, R., Carter, C., Lee, A., Ragland, J.D., Niendam, T., Schlosser, D., Pham, L., Miskovich, T., Vinogradov, S., Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophr. Bull. 41:1 (2015), 250–258, 10.1093/schbul/sbt232.
16. Grande, I., Berk, M., Birmaher, B., Vieta, E., Bipolar disorder. Lancet, 2015, 10.1016/S0140-6736(15)00241-X.
17. WHOQOL Group. 1994. The development of the world health organization quality of life assessment instrument (the WHOQOL). In: Orly, J., Kuyken, W. (Eds.), Quality of Life Assessment: International Perspectives. Springer, Berlin, Heidelberg, pp. 41–57.
18. Gualtieri, C.T., Morgan, D.W., The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials. J. Clin. Psychiatry 69:7 (2008), 1122–1130.
19. Hamilton, M., A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23:1 (1960), 56–62.
20. Jensen, J.H., Støttrup, M.M., Nayberg, E., Knorr, U., Ullum, H., Purdon, S.E., Kessing, L.V., Miskowiak, K.W., Optimising screening for cognitive dysfunction in bipolar disorder: Validation and evaluation of objective and subjective tools. J. Affect. Disord. 187 (2015), 10–19, 10.1016/j.jad.2015.07.039.
21. Joergensen, K., Danske Normer Til Neuropsykologiske Tests. 1st ed., 2012, Dansk Psykologisk Forlag, Viborg, Denmark.
22. Kapczinski, F., Vieta, E., Andreazza, A.C., Frey, B.N., Gomes, F.A., Tramontina, J., Post, R.M., Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav. Rev. 32:4 (2008), 675–692, 10.1016/j.neubiorev.2007.10.005.
23. McIntyre, R.S., Lophaven, S., Olsen, C.K., A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int. J. Neuropsychopharmacol. 17:10 (2014), 1557–1567, 10.1017/S1461145714000546.
24. Miskowiak, K.W., Vinberg, M., Harmer, C.J., Ehrenreich, H., Kessing, L.V., Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression. Psychopharmacology 219:3 (2012), 687–698, 10.1007/s00213-011-2511-1.
25. Miskowiak, K.W., Ehrenreich, H., Christensen, E.M., Kessing, L.V., Vinberg, M., Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. J. Clin. Psychiatry 75:12 (2014), 1347–1355, 10.4088/JCP.13m08839.
26. Miskowiak, K.W., Vinberg, M., Christensen, E.M., Bukh, J.D., Harmer, C.J., Ehrenreich, H., Kessing, L.V., Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 39:6 (2014), 1399–1408, 10.1038/npp.2013.335.
27. Miskowiak, K.W., Ehrenreich, H., Kessing, L.V., Vinberg, M., Dr Miskowiak and colleagues reply. J. Clin. Psychiatry 76:6 (2015), e835–6, 10.4088/JCP.15lr09809a.
28. Miskowiak, K.W., Vinberg, M., Macoveanu, J., Ehrenreich, H., Køster, N., Inkster, B., Paulson, O.B., Kesing, L.V., Skimminge, A., Siebner, H.R., Effects of erythropoietin on hippocampal volume and memory in mood disorders. Biol. Psychiatry 78:4 (2015), 270–277, 10.1016/j.biopsych.2014.12.013.
29. Miskowiak, K.W., Rush, A.J., Gerds, T.A., Vinberg, M., Kessing, L.V., Predictors of treatment success in cognition trials: analyses of randomized, controlled trials of erythropoietin in mood disorders. J. Clin. Psychiatry, 2016 (in press).
30. Miskowiak, K.W., Vinberg, M., Glerup, L., Paulson, O.B., Knudsen, G.M., Ehrenreich, H., Macoveanu, J., Neural correlates of improved executive function following erythropoietin treatment in mood disorders. Psychol. Med., 2016, 1–13, 10.1017/S0033291716000209.
31. Mundt, J.C., Marks, I.M., Shear, M.K., Greist, J.M., The work and social adjustment scale: a simple measure of impairment in functioning. Br. J. Psychiatry 180:5 (2002), 461–464, 10.1192/bjp.180.5.461.
32. Ott, C.V., Bjertrup, A.J., Jensen, J.H., Ullum, H., Sjælland, R., Purdon, S.E., Vieta, E., Kessing, L.V., Miskowiak, K.W., Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools. J. Affect. Disord. 190 (2016), 607–615, 10.1016/j.jad.2015.10.059.
33. Posternak, M.A., Young, D., Sheeran, T., Chelminski, I., Franklin, C.L., Zimmerman, M., Assessing past treatment history: test-retest reliability of the treatment response to antidepressant questionnaire. J. Nerv. Ment. Dis. 192:2 (2004), 95–102.
34. Randolph, C., RBANS Manual: Repeatable Battery for the Assessment of Neuropsychological Status. 1998, The Psychological Corporation, San Antonio, TX.
35. Sargin, D., Friedrichs, H., El-Kordi, A., Ehrenreich, H., Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research. Best Pract. Res. Clin. Anaesthesiol. 24 (2010), 573–594, 10.1016/j.bpa.2010.10.005.
36. Schmidt, M., Rey Auditory Verbal Learning Test – A Handbook. 2004, Western Psychological Services, Los Angeles, CA.
37. Shimizu, Y., Shimizu, Y., Neurocognitive impairments and quality of life in unemployed patients with remitted major depressive disorder. Psychiatry Res. 210:3 (2013), 913–918, 10.1016/j.psychres.2013.08.030.
38. Sirén, A.-L., Fasshauer, T., Bartels, C., Ehrenreich, H., Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system. Neurother.: J. Am. Soc. Exp. Neurother. 6:1 (2009), 108–127, 10.1016/j.nurt.2008.10.041.
39. Strauss, E., Sherman, E., Spreen, O., A Compendium of Neuropsychological tests. Administration, Norms and Commentary. 3rd ed., 2006, Oxford University Press, New York, NY.
40. Svendsen, A.M., Kessing, L.V., Munkholm, K., Vinberg, M., Miskowiak, K.W., Is there an association between subjective and objective measures of cognitive function in patients with affective disorders?. Nord. J. Psychiatry 66:4 (2012), 248–253, 10.3109/08039488.2011.626870.
41. Tabarés-Seisdedos, R., Balanzá-Martínez, V., Sánchez-Moreno, J., Martinez-Aran, A., Salazar-Fraile, J., Selva-Vera, G., Rubio, C., Mata, I., Gómez-Beneyto, M., Vieta, E., Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up. J. Affect. Disord. 109:3 (2008), 286–299.
42. Vieta, E., Popovic, D., Rosa, A.R., Solé, B., Grande, I., Frey, B.N., Kapczinski, F., The clinical implications of cognitive impairment and allostatic load in bipolar disorder. Eur. Psychiatry: J. Assoc. Eur. Psychiatry 28:1 (2013), 21–29, 10.1016/j.eurpsy.2011.11.007.
43. Wechsler, D., Wechsler Adult Intelligence Scale III. 1997, The Psychological Corporation, San Antonio.
44. Wechsler, D., Wechsler Adult Intelligence Scale-III: Vejledning. 2007, Dansk Psykologisk Forlag, Virum.
45. Young, R.C., Biggs, J.T., Ziegler, V.E., Meyer, D.A., A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry: J. Ment. Sci. 133 (1978), 429–435.